Dexcom ONE+ Receiver

The Dexcom ONE+ Receiver is a compatible display device that shows a Dexcom ONE+ user’s real-time glucose readings. The easy-to-use receiver is small, lightweight, and convenient to keep with you. The Dexcom ONE+ Receiver battery can last for up to 7 days of use on a single battery charge.

This product is only compatible with Dexcom ONE+ products. There is no Share feature with the Dexcom ONE+ Receiver as it does not have cellular data or internet connectivity.

ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you.

Prior to purchase, please review the terms and conditions, which you will accept on purchase of a product.  

Terms and Conditions: 

1. By purchasing the product, you agree to the terms and conditions and accept the warranty information available regarding each product purchased. You agree that you will make a follow up appointment with your healthcare professional.
2. All Dexcom users must review all training materials provided with the product. If the Dexcom user requires further training on the product, they must contact their healthcare professional or contact AMSL Diabetes for further assistance.
3. If glucose alerts and readings do not match symptoms or expectations, user should use a blood glucose meter.
4. It is the Dexcom user’s responsibility to seek appropriate advice when necessary and to use the device as per usage instructions.
5. The warranty conditions for the Dexcom systems can be found on our website. 
   
6. This promotion is only available to Australian residents.
7. AMSL reserves its right to modify the terms and conditions or the contents of the subscription program at any time at their sole discretion. Any changes to the subscription program will be released via AMSL’s website.
8. In compliance with the Privacy Act 1988 (Cth) and AMSL's Privacy Policy, the Dexcom user’s records will be maintained in accordance with the National Privacy Principles.
9. The Dexcom user assigns indemnity to AMSL from and against all claims of whatsoever nature (to the maximum extent permitted by law) relating (whether directly or indirectly) to the Dexcom CGM Systems.
10. This product is continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. It is not indicated for use in patients on dialysis treatment. Receivers, transmitters and sensors are not for resale. Use of non-approved platforms will invalidate the warranty for the receiver, sensor and transmitter.
11. Dexcom and Dexcom ONE+ are registered trademarks of Dexcom, Inc. in the United States and/or other countries.

More Information

Please review the Using Your Dexcom ONE+ Guide before using the ONE+. Indications, contraindications, warnings, precautions, and other important user information can be found in the product instructions that are included with Dexcom ONE+. Discuss with your healthcare professional how you should use the information displayed on Dexcom ONE+ to help manage your glucose levels. The product instructions contain important information on troubleshooting the Dexcom ONE+ and on the performance characteristics of the system.

If your glucose alerts and readings from the Dexcom ONE+ do not match symptoms or expectations, use a blood glucose meter to make treatment decisions.

MAT-7118